North Carolina State University

BlackArch Partners Announces Recent Promotions

Retrieved on: 
Thursday, March 7, 2024

CHARLOTTE, N.C., March 7, 2024 /PRNewswire-PRWeb/ -- BlackArch Partners, a leading middle-market investment bank, is pleased to announce that Will Mackvick has been promoted to Managing Director and Brandon Boor has been promoted to Director.

Key Points: 
  • BlackArch Partners, a leading middle-market investment bank offering a full spectrum of advisory services, is pleased to announce the promotions of Will Mackvick to Managing Director and Brandon Boor to Director.
  • CHARLOTTE, N.C., March 7, 2024 /PRNewswire-PRWeb/ -- BlackArch Partners, a leading middle-market investment bank, is pleased to announce that Will Mackvick has been promoted to Managing Director and Brandon Boor has been promoted to Director.
  • Prior to joining BlackArch, he worked for CapitalSouth Partners as well as in the Listed Derivatives group at Credit Suisse.
  • Mr. Boor's full bio can be found here on the BlackArch website.

Jabali Raises $5M to Build a Generative AI-Powered Game Engine of the Future

Retrieved on: 
Wednesday, March 6, 2024

SAN FRANCISCO and RALEIGH, N.C., March 6, 2024 /PRNewswire/ -- Jabali, an AI company advancing game engines and empowering visionary game designers and developers, announced that it has raised a $5 million seed round led by BITKRAFT Ventures with participation from Sapphire Sport, Sony Innovation Fund, Canonical Ventures, and angels from Amazon, Google AI, Open AI, and Pinterest. The investment will be used to expand the Jabali team, refine proprietary models, and accelerate the product launch.

Key Points: 
  • The company's generative AI-powered game engine will let users create new types of games and interactive experiences without needing extensive game development knowledge.
  • Jabali is creating a purpose-built, closed-loop feedback workflow and technology for video games and interactive experiences, utilizing the advances in multimodal generative AI.
  • Our engine revisits what a game engine can do, enabling more people to make games and new experiences," shared Jabali Founder and CEO, Vatsal Bhardwaj.
  • Jabali is addressing fundamental shifts in game development requiring multi-modal generative AI technology to be built from the core of the game engine.

University of Kentucky Study Finds 11 Bushel Higher Corn Yield with Pivot Bio Microbial Nitrogen

Retrieved on: 
Wednesday, March 6, 2024

AMES, Iowa, March 6, 2024 /PRNewswire/ -- The University of Kentucky Martin-Gatton College of Agriculture, Food and Environment, a leading land-grant institution, recently found that replacing 40 pounds of synthetic nitrogen with Pivot Bio PROVEN® 40 can increase corn yields while reducing reliance on synthetic fertilizer. This study is part of over 400 university-led and on-farm trials conducted in 2023, one of the most significant research endeavors on microbial nitrogen to date.

Key Points: 
  • This study is part of over 400 university-led and on-farm trials conducted in 2023, one of the most significant research endeavors on microbial nitrogen to date.
  • Higher yields suggest that applying microbial nitrogen in furrow can help bridge the nitrogen gap that can occur in fields with cover crop rotations.
  • Preston employs both no-till and cover crop practices in addition to Pivot Bio's microbial nitrogen.
  • Corn yields were similar across both nitrogen fertilizer rates; however, PROVEN 40 applied in furrow increased corn yields across both nitrogen rates.

Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeutic

Retrieved on: 
Monday, February 26, 2024

NEW YORK, Feb. 26, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, announced today that it has completed bioanalytical method development under its prior agreement with Altasciences and plans to further engage Altasciences to perform a key study of mouse blood and plasma analysis from samples collected in Hoth's sponsored scientific research conducted at NC State University.  The blood and plasma samples collected are part of a dose response study in a humanized mouse model. The upcoming study will use the newly validated bioanalytical method developed at Altasciences to test the amount of HT-KIT from the dose response study and help determine how long HT-KIT remains in the blood stream post dosing.

Key Points: 
  • NEW YORK, Feb. 26, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, announced today that it has completed bioanalytical method development under its prior agreement with Altasciences and plans to further engage Altasciences to perform a key study of mouse blood and plasma analysis from samples collected in Hoth's sponsored scientific research conducted at NC State University.
  • The blood and plasma samples collected are part of a dose response study in a humanized mouse model.
  • The upcoming study will use the newly validated bioanalytical method developed at Altasciences to test the amount of HT-KIT from the dose response study and help determine how long HT-KIT remains in the blood stream post dosing.
  • "We are pleased to further engage Altasciences on these studies given its great reputation for full-service solutions including preclinical safety testing, clinical pharmacology and bioanalysis."

AvevoRx Announces National Director of Pharmacy Operations Named to Triad Business Journal's "40 Leaders Under 40"

Retrieved on: 
Thursday, February 22, 2024

GREENSBORO, N.C., Feb. 22, 2024 /PRNewswire-PRWeb/ -- AvevoRx, an independent provider of specialty infusion pharmacy services, is proud to announce its National Director of Pharmacy Operations, Justin R. Dent, PharmD, has been named to the Triad Business Journal's prestigious "40 Leaders Under 40" list. The 2024 list spotlights extraordinary young leaders with significant career achievements who work and are civically engaged in the Triad community of North Carolina.

Key Points: 
  • The 2024 list spotlights extraordinary young leaders with significant career achievements who work and are civically engaged in the Triad community of North Carolina.
  • As its National Director of Pharmacy Operations, Dent ensures the smooth and efficient day-to-day operations of AvevoRx's pharmacy services at scale.
  • Dent's most significant achievements include helping to expand the company's national footprint and experience with pharmacy law and accreditation compliance.
  • "Our founders established a solid base, and we're constantly enhancing our operations to provide specialty pharmacy care to as many patients as possible.

Celularity’s Tri-layer Decellularized, Dehydrated Human Amniotic Membrane Product Investigated as a Carrier of Induced Pluripotent Stem Cell Derived-Limbal Stem Cells in the Treatment of Severe Ocular Surface Disease

Retrieved on: 
Wednesday, February 14, 2024

FLORHAM PARK, N.J., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”) a biotechnology company developing allogeneic cell therapies and advanced biomaterial products, today announced that its abstract “Tri-layer decellularized, dehydrated human amniotic membrane supports proliferation and stemness of limbal stem cells derived from induced pluripotent stem cells” has been accepted as a poster presentation at WBC 2024, the 12th World Biomaterials Congress which will be held on 26-31 May 2024 in Daegu, Republic of Korea, and hosted by the Korean Society for Biomaterials (KSBM). The theme of WBC 2024 is “Convergence in Biomaterials: a vision for the future of healthcare.”

Key Points: 
  • The theme of WBC 2024 is “Convergence in Biomaterials: a vision for the future of healthcare.”
    The study described in the poster presentation investigated Celularity’s tri-layer decellularized, dehydrated human amniotic membrane technology product as a carrier of induced pluripotent stem cell derived-limbal stem cells (iPSC-LSC) which were investigated for the treatment of limbal stem cell deficiency (LSCD).
  • Limbal Stem Cell (LSC) transplant is a recognized method to restore the ocular surface in advanced stem cell deficient corneas.
  • Its Tissue Engineering Lab Team is particularly interested in corneal tissue engineering, focusing primarily on ocular surface regeneration.
  • The off-the-shelf availability of existing commercial tri-layer decellularized, dehydrated human amniotic membrane products, in combination with iPSC-LSCs, may improve patient access to LSCD treatment and the therapeutic management of LSCD.

State Department Announces 2023-2024 Fulbright Top Producing Institutions

Retrieved on: 
Tuesday, February 13, 2024

Fulbright Top Producing Institutions are grouped by Carnegie Classification, and represent the range of institutions engaging with the Fulbright Program and ensuring its broad impact on American communities across the country.

Key Points: 
  • Fulbright Top Producing Institutions are grouped by Carnegie Classification, and represent the range of institutions engaging with the Fulbright Program and ensuring its broad impact on American communities across the country.
  • Lee Satterfield, Assistant Secretary of State for Educational and Cultural Affairs, commended the honorees: "Fulbright's 2023-24 Top Producing Institutions represent the diversity of America's higher education community.
  • The institutions with the highest number of U.S. Scholars within their classification were California State Polytechnic University, Kirkwood Community College (Iowa), Middlebury College (Vermont), the Pennsylvania State University, Salem State University (Massachusetts), and Western Washington University.
  • For more information and stories about the Fulbright Top Producing Institutions, and to view the full list of institutions, visit the Fulbright Top Producing Institutions website .

Celebrating Excellence in Anatomy: AAA Awards Distinguished Members

Retrieved on: 
Thursday, February 8, 2024

ROCKVILLE, Md., Feb. 8, 2024 /PRNewswire/ -- The American Association for Anatomy (AAA) is honored to announce its 2024 awards recipients. Eighteen of the association's 2,455 members have been selected because they advanced AAA's values: community, respect, inclusion, integrity, and discovery. 

Key Points: 
  • ROCKVILLE, Md., Feb. 8, 2024 /PRNewswire/ -- The American Association for Anatomy (AAA) is honored to announce its 2024 awards recipients.
  • Eighteen of the association's 2,455 members have been selected because they advanced AAA's values: community, respect, inclusion, integrity, and discovery.
  • The AAA awards program provides over $650,000 in awards, research grants, and scholarships annually.
  • "Being recognized by my AAA idols, mentors, and peers is a cherished honor, reaffirming my commitment to fostering curiosity, deep understanding, and innovation in anatomy education."

Another ‘First’ for Cottonwood

Retrieved on: 
Tuesday, February 6, 2024

– The famed Kimpton Cottonwood Hotel – birthplace of the Rueben sandwich and butter-brickle ice cream – has added another item to its list of unique amenities: Personal Plants.

Key Points: 
  • – The famed Kimpton Cottonwood Hotel – birthplace of the Rueben sandwich and butter-brickle ice cream – has added another item to its list of unique amenities: Personal Plants.
  • The Cottonwood has long invited guests to bring their furry friends on stays (pets are welcome in all 205 rooms), and now the Cottonwood has become even more of a staycation destination by adding adoptable plants to become Nebraska’s first pet and plant-friendly hotel.
  • But a philodendron or a peace lily can positively affect your mood, too, by alleviating stress and reducing anxiety.
  • “We’re going all-in on healthy living in 2024,” said Dayna Baker, General Manager at Cottonwood.

Kemin Research Leads to FDA Approval of Chromium Propionate for Use in Growing Turkey Diets

Retrieved on: 
Tuesday, January 30, 2024

DES MOINES, Iowa, Jan. 30, 2024 /PRNewswire/ -- Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, conducted extensive research that served as the basis for the U.S. Food and Drug Administration (FDA) Center for Veterinary Medicine's approval of the use of chromium propionate as a source of chromium in growing turkey diets. With this approval, chromium propionate is now approved for use in swine, broiler chickens, cattle, horses, and growing turkey diets. KemTRACE® Chromium from Kemin is the only FDA-reviewed source of chromium propionate on the market today and has been fed to millions of animals around the globe.

Key Points: 
  • With this approval, chromium propionate is now approved for use in swine, broiler chickens, cattle, horses, and growing turkey diets.
  • KemTRACE® Chromium from Kemin is the only FDA-reviewed source of chromium propionate on the market today and has been fed to millions of animals around the globe.
  • KemTRACE Chromium is a highly bioavailable, organic source of chromium propionate that helps stabilize insulin receptors in animals, improving glucose utilization and reducing the negative impacts of stress.
  • With more than 25 years of research and countless peer-reviewed chromium research studies, Kemin paved the path to establish chromium propionate as safe and efficacious.